首页|苏黄止咳胶囊联合布地奈德对慢性阻塞性肺疾病急性加重期痰热阻肺型患者的影响

苏黄止咳胶囊联合布地奈德对慢性阻塞性肺疾病急性加重期痰热阻肺型患者的影响

扫码查看
目的:探讨苏黄止咳胶囊联合布地奈德对慢性阻塞性肺疾病急性加重期(AECOPD)痰热阻肺型患者的效果及对氧化应激指标、炎症反应的影响.方法:选取88例萍乡市第二人民医院2020年1 月—2023 年 1 月收治的AECOPD患者,随机将其分为两组,每组 44 例.对照组采用常规治疗+布地奈德治疗,苏黄组在对照组的基础上联用苏黄止咳胶囊.比较两组临床疗效、不良反应发生情况,以及治疗前后中医症候积分、氧化应激指标、炎症指标.结果:苏黄组临床总有效率较对照组高,治疗后中医症候积分均较对照组低(P<0.05);苏黄组丙二醛(MDA)较对照组低,谷胱甘肽过氧化物酶(GSH-Px)和超氧化物歧化酶(SOD)均较对照组高,差异均有统计学意义(P<0.05);治疗后苏黄组超敏C反应蛋白(hs-CRP)、肿瘤坏死因子-α(TNF-α)及白细胞介素-8(IL-8)均显著低于对照组(P<0.05).两组不良反应总发生率比较,差异无统计学意义(P>0.05).结论:苏黄止咳胶囊联合布地奈德治疗AECOPD痰热阻肺型患者的效果显著,可缓解患者临床症状,减轻氧化应激反应和炎症反应,安全性高.
Effect of Suhuang Zhike Capsules Combined with Budesonide on Patients with Phlegma-heat Obstructing Lung Type with Acute Exacerbation of Chronic Obstructive Pulmonary Disease
Objective:To investigate the effect of Suhuang Zhike Capsules combined with Budesonide on patients with phlegma-heat obstructing lung type with acute exacerbation of chronic obstructive pulmonary disease(AECOPD)and its influence on oxidative stress indexes and inflammatory reaction.Method:A total of 88 patients with AECOPD admitted to Pingxiang NO.2 People's Hospital from January 2020 to January 2023 were randomly divided into two groups,with 44 cases in each group.The control group was treated with conventional treatment+Budesonide,Suhuang group was coadministered with Suhuang Zhike Capsules on the basis of the control group.The clinical efficacy,occurrence of adverse reactions,before and after treatment of TCM syndromes scores,oxidative stress indexes and inflammation indexes were compared between the two groups.Result:The total clinical effective rate of Suhuang group was higher than that of control group,and the TCM syndromes scores after treatment were lower than those of control group(P<0.05).The malondialdehyde(MDA)in Suhuang group was lower than that in control group,and the glutathione peroxidase(GSH-Px)and superoxide dismutase(SOD)in Suhuang group were higher than those in control group,the differences were statistically significant(P<0.05).After treatment,hypersensitive C reactive protein(hs-CRP),tumor necrosis factor-α(TNF-α)and interleukin-8(IL-8)in Suhuang group were significantly lower than those in control group(P<0.05).There was no significant difference in the total incidence of adverse reactions between the two groups(P>0.05).Conclusion:Suhuang Zhike Capsules combined with Budesonide has a significant effect in the treatment of patients with phlegma-heat obstructing lung type with AECOPD,which can relieve clinical symptoms,reduce oxidative stress and inflammatory reaction,and has high safety.

Suhuang Zhike CapsulesBudesonideAECOPDPhlegma-heat obstructing lung type

胡立、何芳志、郭晓云、陈虎、吴军、喻承伟

展开 >

萍乡市第二人民医院呼吸与危重症医学科 江西 萍乡 337000

萍乡市第二人民医院重症医学科 江西 萍乡 337000

苏黄止咳胶囊 布地奈德 慢性阻塞性肺疾病急性加重期 痰热阻肺型

萍乡市科技计划项目

2022py048

2024

中国医学创新
中国保健协会

中国医学创新

影响因子:1.706
ISSN:1674-4985
年,卷(期):2024.21(21)